I In nt tr ro od du uc ct ti io on n. . The deletion (D) allele of the angiotensin-converting enzyme (ACE) gene has been studied in various populations in relation to hypertension (HTN) and type 2 diabetes mellitus (T2DM) with contradictory results. This study sought to determine the association of insertion (I)/D polymorphism of the ACE gene in hypertensive and T2DM subjects in a Malaysian population. M Ma at te er ri ia al ls s a an nd d m me et th ho od ds s. . A total of 260 subjects consisting of 65 HTN, 60 T2DM, 65 T2DM with HTN and 70 controls were recruited. Genotyping was performed by polymerase chain reaction initially and mistyping of DD genotypes was performed with an insertion-specific primer. R Re es su ul lt ts s. . The frequency for II, ID and DD genotypes of the ACE gene was 36.92%, 52.31% and 10.77% in HTN, 40.00%, 41.67% and 18.33% in T2DM, 30.77%, 53.85% and 15.38% in T2DM with HTN and 57.14%, 40.00% and 2.86% in controls, respectively. The frequency for the D allele was 36.92% in HTN, 39.17% in T2DM and 42.31% in T2DM with HTN compared to 22.86% in controls. The genotype and allele frequency of the ACE gene polymorphism differed significantly in patients when compared to controls (p < 0.05). C Co on nc cl lu us si io on n. . The D allele of the ACE gene is associated with essential HTN and T2DM in Malaysian subjects.
Introduction
Hypertension (HTN) is a major public health burden worldwide and it is a growing concern in Malaysia. 1 According to the Second National Health Morbidity Survey 1996 in Malaysia, the prevalence of HTN among adults was found to be 33.0%, 8.3% for type 2 diabetes mellitus (T2DM) and was 4.3% for impaired glucose tolerance. 2 Essential HTN is a multifactorial complex disorder caused by genetic, environmental and demographic factors. 3 The renin-angiotensinaldosterone system (RAAS) is an important system in regulating blood pressure and electrolyte balance. 4 RAAS gene polymorphisms have been extensively studied to determine the genetic susceptibility to HTN. 5 It also plays an important role in the pathogenesis of T2DM as RAAS blockade reduces insulin resistance. 6 The angiotensinconverting enzyme (ACE) gene is a major component in the RAAS and has been studied as a candidate gene for the development of essential HTN. 7 ACE polymorphisms appear to have a significant impact on the progression of HTN and diabetes. ACE (dipeptidyl carboxypeptidase) is a zinc metallopeptidase, which catalyses the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, and through protease activity it also inactivates bradykinin, a potent vasodilator. 8 ACE gene has been mapped to chromosome 17q23 and is encoded by a 21 Kb gene that consists of 26 exons and 25 introns. 9 Insertion/deletion (I/D) polymorphism of a 287 bp Alu repeat sequence in intron 16 of the ACE gene is strongly associated with plasma and cellular ACE levels 10 and it indicates that the polymorphism may modulate the expression of the ACE gene. 11 Several studies have reported the association of the D allele of ACE gene in HTN 12 and T2DM in various populations. 13 However, some studies have failed to show the association with the D allele. 14 The conflicting results of I/D polymorphism of the ACE gene in HTN and other diseases might be due to different ethnic groups and gender. 15, 16 However, to date there is a lack of information on the association of the I/D polymorphism of ACE gene in Malaysian subjects. Therefore, this study was initiated to determine the relationship of I/D polymorphism of the ACE gene in essential hypertensive and type 2 diabetic patients in Malaysian subjects.
Materials and methods

Subjects
The study was approved by the Ethical Committee of the Faculty of Medicine and Health Science, Universiti Putra Malaysia (UPM). A total of 190 patients were recruited for this study who were consecutively attending from April 2006 to April 2007 at UPM Physician Clinic, Hospital Kuala Lumpur. HTN was defined as an elevated systolic blood pressure (SBP) ≥ 140 mmHg and sustained diastolic blood pressure (DBP) ≥ 90 mmHg or who were currently receiving antihypertensive therapy. Type 2 diabetic subjects were recruited using American Diabetes Association criteria -a fasting plasma glucose level of more than 7.0 mmol/L. Unrelated healthy individuals were collected randomly (no age-sex matched controls) from the UPM staff and volunteers. Control samples were defined as those with blood pressure of < 140/90 mmHg, fasting blood glucose level was below 7.0 mmol/L, without family history of HTN and diabetes, and none of them were receiving any medications at the time of participation. Blood pressure was measured in the subjects who had been seated and rested for 5 minutes and taken twice to calculate the mean SBP and DBP. The subjects were divided into four main groups: HTN (Group 1, n = 65); T2DM (Group 2, n = 60); T2DM with HTN (Group 3, n = 65); and controls (Group 4, n = 70). The subjects were also categorised under the three major ethnic groups in Malaysia: Malay, Chinese and Indians. A questionnaire in both Malay and English language was obtained to assess the socio-demographic factors, history of HTN, diabetes and co-morbidities. Written informed consent was obtained from all the subjects who participated in this study.
Sample collection and biochemical analysis
Four to five millilitres of blood samples were collected from the peripheral blood leukocytes into an EDTA tube (Becton Dickinson, NJ, USA) by a qualified phlebotomist. Plasma was separated from the blood by centrifugation method and stored at −20ºC for further analysis. Individual weight and height were obtained to calculate body mass index (BMI) using the formula, weight (kg)/[height (m)] 2 . Plasma samples were analysed on a Hitachi-912 Autoanalyser (Hitachi, Germany) using kits supplied by Roche Diagnostics (Mannheim, Germany) to determine the level of triglycerides (TG), high density lipoprotein cholesterol (HDL-C) and total cholesterol (TC). Low density lipoprotein cholesterol (LDL-C) was calculated by Friedewald formula. Lipid profiles were classified under the category of The Third Report of the National Cholesterol Education Program guidelines. 17
Genotyping methods
Genomic DNA was extracted from peripheral blood using DNA isolation kit (BioBasic Inc., Canada). The purity of extracted DNA was checked using Biophotometer (Eppendorf, Germany).
To determine the I/D polymorphism of ACE gene, a flanking primer pair 18 5'-CTGGAGAC-CACTCCCATCCTTTCT-3' and 5'-GATGTGGCCAT-CACATTCGTCACG-AT-3' (synthesised by Research Biolabs, Malaysia) was amplified by polymerase chain reaction (PCR) technique. PCR amplification was performed with a 25 µl reaction mixture that contained 20 pmol of each primer, 0.4 mmol/L each dNTP, 2 mmol/L MgCl 2 , 1× Taq buffer and 1 unit of NEB Taq DNA polymerase (New England Biolabs, Beverly, MA, USA). The PCR cycling conditions were carried out on an iCycler machine (BioRad Laboratories, Hercules, CA, USA) with an initial denaturation step of 5 minutes at 94°C, followed by 30 cycles of denaturation at 94°C for 30 seconds, annealing at 58°C for 1 minute and extension at 72°C for 2 minutes, followed by a final extension for 5 minutes at 72°C before the storage of the samples at 4°C. PCR products were separated by agarose gel electrophoresis (Promega, Madison, USA) performed in Origins electrophoresis tank (Elchrom Scientific AG, Switzerland). DNA fragments were stained in ethidium bromide and visualised by Alpha Imager (Alpha Innotech, San Leandro, CA, USA) under UV light. The PCR fragments showed three genotypes: a 490 bp band (II), a 190 bp band (DD), and both a 490 and a 190 bp band (ID). Mistyping of ID heterozygotes as D homozygotes may occur. To increase the specificity of DD genotyping, PCR amplifications were also performed with an insertion-specific primer pair 5'-TGGGACCACAGCGCCCGCCACTAC-3' and 5'-TCGCCAGCCCTCCCATGCCC-ATAA-3' 19 used in each sample which had the DD genotype. PCR conditions were performed with 1 minute initial denaturation at 94°C, followed by 30 cycles of denaturation at 94°C for 30 seconds, annealing at 67°C for 45 seconds and extension at 72°C for 2 minutes. Under these conditions, the reaction showed the presence of an I allele at a 335 bp amplicon and no products in samples that were homozygous for DD genotype. Identical results were obtained when genotyping was performed on two separate occasions.
Statistical analysis
Clinical characteristics of all the subjects were expressed as mean±SD. All the statistical analysis were carried out using SPSS (Chicago, IL, USA) software version 14.0 for Microsoft Windows. Continuous variables were compared between the groups by using two-tailed student's t-test. Allelic frequencies were calculated by genecounting method and the genotype distribution with Hardy-Weinberg expectations by a chisquared test. One-way ANOVA test was used to compare the group means. using General Linear Model ANOVA. A level of p < 0.05 was considered statistically significant.
Results
Baseline characteristics
Three hundred subjects were approached and 260 subjects were included, since some chose not to take part or were excluded due to inconsistent results and extreme values. The baseline characteristics of all the subjects enrolled in this study are shown in table 1. There was no significant difference found in BMI between the hypertensive group and the control group (p > 0.05); however, it significantly differed in T2DM and T2DM with HTN groups when compared to the control group. The variables SBP and DBP at the time of participation were significantly higher in hypertensive groups than the control group (p < 0.001). Blood glucose levels gave significant differences in case subjects analysed. HDL-C was significantly different only in diabetic groups (p < 0.05), but not in hypertensive groups. In contrast, LDL-C levels, TG and TC did not show statistical differences in any of the groups included in the study.
Genotyping results
In this study, we found that the D allele of the ACE gene was in statistically significant association with HTN and type 2 diabetes as compared to control subjects in Malaysian population. The genotypes of I/D polymorphism were allotted on the basis of the pattern of bands on electrophoresis using standard methods (figure 1). The distribution of genotypes in these subjects showed deviation from Hardy-Weinberg equilibrium (p < 0.05). The genotypic and allelic distributions among the subjects are shown in table 2. In Malaysian subjects, the genotypic frequencies of ACE gene for II, ID and DD were 36.92%, 52.31% and 10.77%, respectively in Group 1 (p = 0.028), whereas in Group 2 40.00%, 41.67% and 18.33% (p = 0.008) were observed, respectively, and in Group 3 the genotypes were 30.77%, 53.85% and 15.38% (p = 0.002), respectively, as compared to 57.14%, 40.00% and 2.86% in control subjects. The derived allele frequency for D allele was 36.92% in HTN, 39.17% in T2DM and 42.31%
in T2DM with HTN as compared to 22.86% of control subjects (p = 0.002). It can be seen that the frequencies of this polymorphism were strongly associated with HTN and T2DM (p < 0.05).
The effect of gender on HTN and T2DM was also considered in this study in respect of the ACE gene. Table 3 shows the genotype and allelic distributions of the I/D polymorphism among males and females in cases and controls. There was no significant gender-related preferential distribution differences in either genotypic or allelic distribution between male and female subjects (p > 0.05). In addition, we stratified the data according to the three main ethnic groups in Malaysian population. We also found no significant difference (p > 0.05) in the genotype frequencies among Malays, Chinese and Indians in either cases or controls (data not shown). Table 4 shows the p value and odds ratio between the genotypes of the ACE gene and the subject groups. The odds ratio was high for DD vs. ID in the patients as compared to controls, particularly in Group 3 vs. 4 the odds ratio was very high (10.00; 95% CI: 2.00-50.04). The values were not significant for the genotypes DD vs. ID between the patients and controls. In the case of Groups 2 and 3 comparison to Group 4 for the genotypes ID vs. II was not significant (p > 0.05). Individuals homozygous for the D allele appeared to be at greater risk as compared to those with the I allele (2.26; 95% CI: 1.45-3.53), followed by heterozygous genotypes (2.07; 95% CI: 1.16-3.68). To identify the confounding factors for I/D polymorphism, we performed ANOVA using the General Linear Model procedure to compare the association between the I/D polymorphism genotypes (II, ID, DD) and clinical parameters (table 5) . There were no significant differences found in age, SBP, DBP and BMI between the genotypes of I/D polymorphism and the risk factors.
Discussion
An increased plasma and serum ACE level was genetically determined by a 287 bp fragment of I/D polymorphism in the 16th intron of the ACE gene at chromosome 17. 10 The presence/insertion of this sequence is represented as homozygosity II, ID for heterozygosity, while DD represents the absence/ deletion of a 287 bp Alu repeated sequence. DD genotypes and the D allele compared to II genotypes and the I allele have a strong association with increased risk of myocardial infarction, 20 HTN, 18 diabetes and its complications. 21 Conversely, many studies have pointed out that DD genotypes failed to show an association in HTN 14 and diabetes. 22 A strong association of the I allele was found in an Australian population with familial HTN. 23 These controversial findings prompted us to study the polymorphism of the ACE gene in Malaysian hypertensive and type 2 diabetic subjects, probably for the first time.
In this study, we found that DD genotypes and the D allele of the ACE gene were strongly associated with HTN and type 2 diabetes as compared to healthy individuals (p < 0.05) in Malaysian subjects (table 2) . These findings are in agreement with some previous studies 12, 22 done in other populations where the DD genotype and D allele of ACE gene showed high prevalence of 93.33% and 81.39%, respectively, in patients as compared to controls. The frequency of the D allele in hypertensive patients was found to be higher than in control subjects (p = 0.016), in agreement with previous studies, 12 and for T2DM with or without HTN we found a significant difference compared with controls (p < 0.01), similar to studies done in a Taiwanese population. 24 However, no significant difference (p > 0.05) was found between males and females in Malaysian subjects related to ACE genotypes, which is in accordance with previous studies. 25 The literature shows that, association of I/D polymorphism has been analysed in ischaemic heart disease in Malaysian population and showed no significant difference compared to patients (p > 0.05), while there was a significant difference found in diastolic dysfunction patients as compared to controls (p < 0.001), which is similar to this study. Say et al. 26 showed that the M235T polymorphism of the angiotensinogen gene was associated with HTN subjects in a Malaysian population, which clearly shows that RAAS polymorphism plays an important role in the pathogenesis of HTN in Malaysian subjects. However, a recent study failed to show an association of the BglI dimorphism of the renin gene with HTN, with or without T2DM, in Malaysian subjects. 27 The clinical characteristics of the hypertensive group and the distribution of ACE genotypes in relation to age, BMI, SBP and DBP are similar to a study done in Malaysian hypertensive subjects with respect to angiotensinogen and endothelial nitric oxide synthase gene polymorphisms 28 and to type 2 diabetic subjects in Taiwanese 29 and Iranian populations. 30 However, there was no association with respect to gender, ethnicity and other confounding factors. The discrepancies may be due to the racial differences or heterogeneity of the population sampling bias or possibly environmental factors may contribute to the negative associations. 31 The present study has some limitations, due to randomised control design (no agesex matched controls were used), so that the control subjects were relatively young compared to the case subjects. Although our study sample was relatively small as compared with other epidemiological and association studies, the result of this study supports the hypothesis that the DD genotype/D allele has a strong association with HTN and type 2 diabetes. However, further studies with larger sample size are necessary to confirm the association of the I/D polymorphism of the ACE gene and further investigation is needed to know the possible role of other polymorphisms of RAAS genes in relation to essential HTN and type 2 diabetes in Malaysian subjects.
Conclusion
The present study provides strong evidence for the association of I/D polymorphism of ACE gene in Malaysian hypertensive and type 2 diabetic subjects. The D allele of the I/D polymorphism of ACE gene is proved to be an important genetic marker for essential HTN and T2DM in Malaysian subjects.
